Therefore, a number of studies have focused on the treatment of hepatic fibrosis by targeting PDGF, PDGFR and molecules related to the PDGF intracellular signalling transduction pathway, and have achieved a favourable antifibrogenic effect. The gene discussed is PDGFRB; the disease is Hepatic fibrosis.